Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis.
about
Omega 6 fatty acids for the primary prevention of cardiovascular diseaseAre all n-3 polyunsaturated fatty acids created equal?Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study.High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins.Unraveling the complex relationship triad between lipids, obesity, and inflammationSubstitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects.The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agentsNo positive influence of ingesting chia seed oil on human running performance.Effect of dietary alpha-linolenic acid on blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials.Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.Plasma polyunsaturated fatty acids and the decline of renal function.Alpha-linolenic acid and risk of nonfatal acute myocardial infarction.Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review.Mauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities.Omega-3 fatty acids: a growing ocean of choices.The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease.Predictors for Reporting of Dietary Assessment Methods in Food-based Randomized Controlled Trials over a Ten-year Period.Lignan content of the flaxseed influences its biological effects in healthy men and women.Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective.Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.Effect of conjugated linoleic acid on blood inflammatory markers: a systematic review and meta-analysis on randomized controlled trials.Plasma n-3 and n-6 Fatty Acids Are Differentially Related to Carotid Plaque and Its Progression: The Multi-Ethnic Study of Atherosclerosis.Unsaturated Fatty Acids Improve Atherosclerosis Markers in Obese and Overweight Non-diabetic Elderly Patients.Effects on markers of inflammation and endothelial cell function of three ad libitum diets differing in type and amount of fat and carbohydrate: a 6-month randomised study in obese individuals.Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors.Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis
P2860
Q24187758-3B0BC366-6C51-46D0-AC7C-10B498A03B29Q27497371-FE24A589-4F58-451A-ACB6-F75B32BF12FFQ33819770-732188D0-5BCB-49CB-917E-F1026A0669FFQ33908679-9366B53E-8FAC-4E6C-A16A-1AC14810F363Q34042152-7E7B8D58-7B6D-402C-8193-45E2B4342443Q34126000-1EC311B2-4A1D-4375-B1EB-E82CD77EF195Q34471990-7DAA5C2F-3DF1-4CF6-B5B0-D95F3E29CD2AQ34901492-E35B5256-F75A-4374-AF02-77B4D9564C0DQ35658179-CB9B27DA-73B1-4713-BE8E-7669A900779AQ36301701-A4C22C9D-D081-44CD-AAA0-D544FF59CB71Q36838201-76006152-860D-48F4-8FAD-F63FE0D46734Q37024566-8C0D32B6-3DED-41EB-AB27-155D3BD465D6Q37104534-0A374D36-CBFB-41EC-B626-F484ED4F38DDQ37343178-85AAB580-1C14-45A9-9263-310454DCD3FBQ37349807-0E2FB83B-F054-4533-ABD2-B3067803069DQ37427120-B386A8B3-F427-4A7B-BA02-677678E243CFQ38176274-9025170E-7AA0-4448-8014-3490753F5C6CQ38185266-656B3D16-D73A-46AF-ADCE-15AFC216E88DQ38554771-02BAFB60-D727-45F6-82BE-A6B45104E514Q43763419-1BD70779-662A-49FF-8D06-5041033297DCQ46200000-3FF9D90A-380C-45BB-84AB-AE264F61E3FAQ46609462-A52C3CF7-3ADE-487B-880A-BACF72B8DC4CQ47244002-1E3390B4-4F48-480D-AE92-B90B81B4B448Q50077478-669B9331-7832-4F07-BC75-C4AC66CC4131Q51021307-710577E0-F39E-4FC9-AEAA-9E9238BE312FQ51379285-8F20272F-D5C2-4CAC-A8B9-94198FF837C2Q51393272-1E441824-7B68-48CE-ACB3-1C5C9D0D8785Q55234705-C163B429-508D-46DA-98AA-EE1B3AA86F82Q58550683-8C6162CD-615C-47D1-945D-B483DCFBF8A2
P2860
Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@en
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@nl
type
label
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@en
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@nl
prefLabel
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@en
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@nl
P2093
P2860
P356
P1476
Increased alpha-linolenic acid ...... on markers of atherosclerosis.
@en
P2093
B Meyboom-de Jong
J D Lefrandt
J W Cohen Tervaert
P L van Haelst
W J E Bemelmans
P2860
P2888
P304
P356
10.1038/SJ.EJCN.1601938
P577
2004-07-01T00:00:00Z